StockWatch
·
Ophthalmic Goods
Quarterly ResultApr 29, 2026, 04:55 PM

BLCO Q1 Revenue $1.24B; Net Loss $(70)M; EPS $(0.20)

AI Summary

Bausch & Lomb Corp reported Q1 2026 revenues of $1.24 billion, an increase from $1.14 billion in Q1 2025. The company significantly reduced its net loss to $(70) million, or $(0.20) per share, compared to a net loss of $(211) million, or $(0.60) per share, in the prior year period. Operating income improved to $33 million from an operating loss of $(83) million year-over-year, and cash flow from operations turned positive.

Key Highlights

  • Q1 2026 Revenue $1.24B, up from $1.14B in Q1 2025.
  • Q1 2026 Net Loss $(70)M, significantly reduced from $(211)M in Q1 2025.
  • Q1 2026 Basic & Diluted EPS $(0.20), improved from $(0.60) in Q1 2025.
  • Q1 2026 Operating Income $33M, compared to $(83)M operating loss in Q1 2025.
  • Q1 2026 Net cash provided by operating activities $32M, up from $(25)M used in Q1 2025.
  • Product sales $1.239B in Q1 2026, up from $1.133B in Q1 2025.
  • Total assets $13.78B as of March 31, 2026, down from $14.02B as of Dec 31, 2025.
  • Long-term debt $5.031B as of March 31, 2026, slightly down from $5.043B as of Dec 31, 2025.